Incontinence, nocturnal enuresis, nocturia

Guidelines (1)
Drug Sections (1)

Incontinence, nocturnal enuresis, nocturia in the News

Low-dose desmopressin launched as first treatment for nocturia in over 65s

Low-dose desmopressin launched as first treatment for nocturia in over 65s

Noqdirna is a new low-dose, orally disintegrating formulation of desmopressin that is indicated for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults of all ages.

Generic oxybutynin oral solution now available

Mirabegron: risk of severe hypertension

Mirabegron: risk of severe hypertension

Mirabegron (Betmiga) is associated with a risk of severe hypertension, cerebrovascular and cardiac events, and is now contraindicated in patients with severe uncontrolled hypertension, the MHRA has advised.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases